Lentiviral vectors pseudotyped with envelope glycoproteins derived from human parainfluenza virus type 3

Biotechnology Progress

Volumn 20, Issue 6, 2004, Pages 1810-1816

  Jung, Cindy ^a   Grzybowski, Bradley N ^a   Tong, Suxiang ^b   Cheng, LiTeng ^b   Compans, Richard W ^b   Le Doux, Joseph M ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; CELLS; ENZYME KINETICS; GENE TRANSFER; LIPIDS; PROTEINS;

EPITHELIAL CELLS; GLYCOPROTEINS; LENTIVIRAL VECTORS; LIPID BILAYERS;

VIRUSES;

F PROTEIN, PARAINFLUENZA VIRUS 3; HN PROTEIN; HYBRID PROTEIN; VIRUS FUSION PROTEIN;

ARTICLE; BIOSYNTHESIS; CELL LINE; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; KIDNEY; LENTIVIRINAE; METABOLISM; METHODOLOGY; PARAINFLUENZA VIRUS 3; PROTEIN ENGINEERING;

CELL LINE; GENETIC VECTORS; HN PROTEIN; HUMANS; KIDNEY; LENTIVIRUS; PARAINFLUENZA VIRUS 3, HUMAN; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; TRANSDUCTION, GENETIC; VIRAL FUSION PROTEINS;

HUMAN PARAINFLUENZA VIRUS 3; LENTIVIRUS; RNA VIRUSES;

EID: 10044248384     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp049867h     Document Type: Article

References (36)

1. Pfeifer, A.; Verma, I. M. Gene therapy: promises and problems. Annu. Rev. Genomics Hum. Genet. 2001, 2, 177-211.
2. Mulligan, R. C. The basic science of gene therapy. Science 1993, 260, 926-32.
3. Thomas, C. E.; Ehrhardt, A. et al. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 2003, 4, 346-58.
4. Clapham, P. R.; McKnight, A. Cell surface receptors, virus entry and tropism of primate lentiviruses. J. Gen. Virol. 2002, 83, 1809-29.
5. Reiser, J.; Harmison, G. et al. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 15266-71.
6. Beyer, W. R.; Westphal, M. et al. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range. J. Virol. 2002, 76, 1488-95.
7. Stitz, J.; Buchholz, C. J. et al. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Virology 2000, 273, 16-20.
8. Sinn, P. L.; Hickey, M. A. et al. Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J. Virol. 2003, 77, 5902-10.
9. Emi, N.; Friedmann, T. et al. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J. Virol. 1991, 65, 1202-7.
10. Arai, T.; Matsumoto, K. et al. A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines. J. Virol. 1998, 72, 1115-21.
11. Yang, Y.; Vanin, E. F. et al. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Human Gene Ther. 1995, 6, 1203-13.
12. Johnson, L. G.; Olsen, J. C. et al. Pseudotyped human lentiviral vector-mediated gene transfer to airway epithelia in vivo. Gene Ther. 2000, 7, 568-74.
13. Collins, P. L.; Chanock, R. M. et al. Parainfluenza viruses. In Fields Virology. Fields, B. N., Knipe, D. M., Howley, P. M. et al., Eds.; Philadelphia, Lippincott-Raven Publishers: Philadelphia, 1996; pp 1205-1243.
14. Ray, R. and Compans, R. W. Monoclonal antibodies reveal extensive antigenic differences between the hemagglutinin-neuraminidase glycoproteins of human and bovine parainfluenza 3 viruses. Virology 1986, 148, 232-36.
15. Niwa, H.; Yamamura, K. et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108, 193-99.
16. Smith, R. F. Microscopy and Photomicrography; CRC Press: Boca Raton, 1994
17. Le Doux, J. M.; Landazuri, N. et al. Complexation of retrovirus with cationic and anionic polymers increases the efficiency of gene transfer. Human Gene Ther. 2001, 12, 1611-21.
18. Rothen-Rutishauser, B.; Kramer, S. D. et al. MDCK cell cultures as an epithelial in vitro model: cytoskeleton and tight junctions as indicators for the definition of age-related stages by confocal microscopy. Pharm. Res. 1998, 15, 964-71.
19. Bosch, V.; Kramer, B. et al. Inhibition of release of lentivirus particles with incorporated human influenza virus haemagglutinin by binding to sialic acid-containing cellular receptors. J. Gen. Virol. 2001, 82, 2485-94.
20. Wang, G.; Zabner, J. et al. Increasing epithelial junction permeability enhances gene transfer to airway epithelia in vivo. Am. J. Respir. Cell Mol. Biol. 2000, 22, 129-38.
21. Hatziioannou, T.; Valsesia-Wittmann, S. et al. Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses. J. Virol. 1998, 72, 5313-7.
22. Lin, A. H.; Kasahara, N. et al. Receptor-specific targeting mediated by the coexpression of a targeted murine leukemia virus envelope protein and a binding-defective influenza hemagglutinin protein. Hum. Gene Ther. 2001, 12, 323-32.
23. Dong, J.; Roth, M. G. et al. A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range. J. Virol. 1992, 66, 7374-82.
24. Sandrin, V.; Boson, B. et al. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood 2002, 100, 823-32.
25. Bachrach, E.; Marin, M. et al. Efficient cell infection by Moloney murine leukemia virus-derived particles requires minimal amounts of envelope glycoprotein. J. Virol. 2000, 74, 8480-6.
26. Kobayashi, M.; Iida, A. et al. Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus. J. Virol. 2003, 77, 2607-14.
27. Mammano, F.; Salvatori, F. et al. Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells. J. Virol. 1997, 71, 3341-5.
28. Spiegel, M.; Bitzer, M. et al. Pseudotype formation of Moloney murine leukemia virus with Sendai virus glycoprotein F. J. Virol. 1998, 72, 5296-302.
29. Tailor, C. S.; Takeuchi, Y. et al. Mutation of amino acids within the gibbon ape leukemia virus (GALV) receptor differentially affects feline leukemia virus subgroup B, simian sarcoma-associated virus, and GALV infections. J. Virol. 1993, 67, 6737-41.
30. Yao, Q.; Hu, X. et al. Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces. J. Virol. 1997, 71, 650-6.
31. Tong, S.; Compans, R. W. Alternative mechanisms of interaction between homotypic and heterotypic parainfluenza virus HN and F proteins. J. Gen. Virol. 1999, 80, 107-15.
32. Heminway, B. R.; Yu, Y. et al. Paramyxovirus mediated cell fusion requires coexpression of both the fusion and hemagglutinin-neuraminidase glycoproteins. Virus Res. 1994, 31, 1-16.
33. Porotto, M.; Murrell, M. et al. Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: an HN mutation diminishes the rate of F activation and fusion. J. Virol. 2003, 77, 3647-54.
34. Kowolik, C. M.; Yee, J. K. Preferential transduction of human hepatocytes with lentiviral vectors pseudotyped by Sendai virus F protein. Mol. Ther. 2002, 5, 762-9.
35. Christodoulopoulos, I.; Cannon, P. M. Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentivirus vectors. J. Virol. 2001, 75, 4129-38.
36. Hohne, M.; Thaler, S. et al. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles. Virology 1999, 261, 70-8.